Skip to main content
Top
Published in: Indian Journal of Gastroenterology 6/2022

17-12-2022 | Metastasis | Original Article

Luminal mapping reveals mesenteric predominance of colonic adenomas and adenocarcinomas

Authors: Jim G. Castellanos, Sameer K. Sharma, Koiana Trencheva, Jeffrey W. Milsom, Parul J. Shukla

Published in: Indian Journal of Gastroenterology | Issue 6/2022

Login to get access

Abstract

Background

Previous studies have examined the relationship between colorectal tumor distribution and metastasis, but the tumor luminal location and associative risk factors promoting tumor growth remain unknown.

Methods

In this study, we mapped the luminal distribution of human colonic adenomas/adenocarcinomas and their association with various physiologic parameters.

Results

We identified a mesenteric predominance for colonic adenomas and adenocarcinomas.

Conclusion

The findings of this study raise the possibility of novel mechanistic pathways in the development of adenomas and subsequent transformation into adenocarcinomas.
Literature
1.
go back to reference Veldkamp R, Kuhry E, Hop WCJ, et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol. 2005;6:477–84. Veldkamp R, Kuhry E, Hop WCJ, et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol. 2005;6:477–84.
2.
go back to reference Benevento A, Boni L, Dionigi G, et al. The mesenteric and antimesenteric location of colorectal cancer: the relationship with lymph nodes metastases. Surgeon. 2004;2:214–20.CrossRefPubMed Benevento A, Boni L, Dionigi G, et al. The mesenteric and antimesenteric location of colorectal cancer: the relationship with lymph nodes metastases. Surgeon. 2004;2:214–20.CrossRefPubMed
3.
go back to reference Cucino C, Buchner AM, Sonnenberg A. Continued rightward shift of colorectal cancer. Dis Colon Rectum. 2002;45:1035–40. Cucino C, Buchner AM, Sonnenberg A. Continued rightward shift of colorectal cancer. Dis Colon Rectum. 2002;45:1035–40. 
4.
go back to reference Yang J, Du XL, Li ST, et al. Characteristics of differently located colorectal cancers support proximal and distal classification: a population-based study of 57,847 patients. PLoS One. 2016;11:e0167540. Yang J, Du XL, Li ST, et al. Characteristics of differently located colorectal cancers support proximal and distal classification: a population-based study of 57,847 patients. PLoS One. 2016;11:e0167540.
5.
go back to reference Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe. 2014;15:317–28. Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe. 2014;15:317–28. 
6.
go back to reference Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–306. Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:1298–306. 
Metadata
Title
Luminal mapping reveals mesenteric predominance of colonic adenomas and adenocarcinomas
Authors
Jim G. Castellanos
Sameer K. Sharma
Koiana Trencheva
Jeffrey W. Milsom
Parul J. Shukla
Publication date
17-12-2022
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 6/2022
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-022-01285-w

Other articles of this Issue 6/2022

Indian Journal of Gastroenterology 6/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.